Literature DB >> 22760457

[Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis].

W Eich1, W Häuser, B Arnold, W Jäckel, M Offenbächer, F Petzke, M Schiltenwolf, M Settan, C Sommer, T Tölle, N Uçeyler, P Henningsen.   

Abstract

BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011.
MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND
CONCLUSION: The clinical diagnosis of FMS can be established by the American College of Rheumatology (ACR) 1990 classification criteria (with tender point examination), by the modified preliminary diagnostic ACR 2010 criteria or by the diagnostic criteria of the German interdisciplinary guideline (AWMF) on FMS. The English full-text version of this article is available at SpringerLink (under "Supplemental").

Entities:  

Mesh:

Year:  2012        PMID: 22760457     DOI: 10.1007/s00482-012-1169-x

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  58 in total

1.  [Etiology and pathophysiology of fibromyalgia syndrome].

Authors:  C Sommer; W Häuser; M Burgmer; R Engelhardt; K Gerhold; F Petzke; T Schmidt-Wilcke; M Späth; T Tölle; N Uçeyler; H Wang; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

2.  [Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].

Authors:  U Marschall; B Arnold; W Häuser
Journal:  Schmerz       Date:  2011-08       Impact factor: 1.107

3.  Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample.

Authors:  Kevin P White; Warren R Nielson; Manfred Harth; Truls Ostbye; Mark Speechley
Journal:  J Rheumatol       Date:  2002-03       Impact factor: 4.666

4.  [Validation of the German version of the Regional Pain Scale for the diagnosis of fibromyalgia syndrome].

Authors:  W Häuser; S Schild; M Kosseva; S Hayo; H von Wilmowski; R Alten; J Langhorst; W Hofmann; J Maus; H Glaesmer
Journal:  Schmerz       Date:  2010-06       Impact factor: 1.107

Review 5.  Statin myopathy: a review of recent progress.

Authors:  Andrew L Mammen; Anthony A Amato
Journal:  Curr Opin Rheumatol       Date:  2010-11       Impact factor: 5.006

Review 6.  Fibromyalgia. 1. Review of a common rheumatologic syndrome.

Authors:  P K Hench; M M Mitler
Journal:  Postgrad Med       Date:  1986-11-15       Impact factor: 3.840

7.  Toward characterization and definition of fibromyalgia severity.

Authors:  Stuart Silverman; Alesia Sadosky; Chris Evans; Yating Yeh; Jose Ma J Alvir; Gergana Zlateva
Journal:  BMC Musculoskelet Disord       Date:  2010-04-08       Impact factor: 2.362

8.  Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises.

Authors:  Phillip J Mease; Lesley M Arnold; Leslie J Crofford; David A Williams; I Jon Russell; Louise Humphrey; Linda Abetz; Susan A Martin
Journal:  Arthritis Rheum       Date:  2008-07-15

9.  Fibrositis syndrome: a historical perspective.

Authors:  H Smythe
Journal:  J Rheumatol Suppl       Date:  1989-11

10.  Prevalence of fibromyalgia: a survey in five European countries.

Authors:  Jaime C Branco; Bernard Bannwarth; Inmaculada Failde; Jordi Abello Carbonell; Francis Blotman; Michael Spaeth; Fernando Saraiva; Francesca Nacci; Eric Thomas; Jean-Paul Caubère; Katell Le Lay; Charles Taieb; Marco Matucci-Cerinic
Journal:  Semin Arthritis Rheum       Date:  2009-02-27       Impact factor: 5.532

View more
  20 in total

1.  [Chronic pain in general practice : Results from pain specialists].

Authors:  A Heymanns; H Rudolf; H Schneider-Nutz; K Salem; K Strick; M Zenz
Journal:  Schmerz       Date:  2017-08       Impact factor: 1.107

Review 2.  [Fibromyalgia syndrome: A disease of the small nerve fibers?].

Authors:  N Üçeyler; C Sommer
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

Review 3.  [Definition, classification, clinical diagnosis and prognosis of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles].

Authors:  W Eich; K-J Bär; M Bernateck; M Burgmer; C Dexl; F Petzke; C Sommer; A Winkelmann; W Häuser
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

Review 4.  [Musculoskeletal-related chest pain].

Authors:  C Sturm; T Witte
Journal:  Internist (Berl)       Date:  2017-01       Impact factor: 0.743

Review 5.  [Pain syndrome of the musculoskeletal system in children and adolescents].

Authors:  L Höfel; N Draheim; R Häfner; J P Haas
Journal:  Z Rheumatol       Date:  2016-04       Impact factor: 1.372

6.  [Treatment of fibromyalgia syndrome with gamma-hydroxybutyrate : A randomized controlled study].

Authors:  E Reuter; S Tafelski; K Thieme; C West; U Haase; L Beck; M Schäfer; C Spies
Journal:  Schmerz       Date:  2017-04       Impact factor: 1.107

7.  [Whole body hyperthermia in pain therapy. A controlled trial on patients with fibromyalgia].

Authors:  J Walz; J Hinzmann; I Haase; T Witte
Journal:  Schmerz       Date:  2013-02       Impact factor: 1.107

8.  [Mental disorders in patients with fibromyalgia syndrome: screening in centres of different medical specialties].

Authors:  A Galek; B Erbslöh-Möller; V Köllner; H Kühn-Becker; J Langhorst; F Petermann; U Prothmann; A Winkelmann; W Häuser
Journal:  Schmerz       Date:  2013-06       Impact factor: 1.107

Review 9.  WITHDRAWN: Anticonvulsants for fibromyalgia.

Authors:  Nurcan Üçeyler; Claudia Sommer; Brian Walitt; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2017-10-09

Review 10.  Fibromyalgia in Older Individuals.

Authors:  Amir Minerbi; Mary-Ann Fitzcharles
Journal:  Drugs Aging       Date:  2021-07-08       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.